Ex vivo assays of CEM cells cultured and treated in the three dimensional cultures - 07/07/10
, Boguslaw Tomanek a, b, c, d, Erika Lattová e, Hélène Perreault e, Gino Fallone b, d
Corresponding author. Tel.: +001 780 989 4333; fax: +001 403 221 3230.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
This study was aimed at the applications of an ex vivo assays to characterization of CEM (Human T-Lymphoblastoid) cells. CEM cells were cultured in three dimensional (3-D) geometry in the Hollow Fibre Bioreactor (HFB) device. The cells were treated with Herceptin, anti-HER-2 (clone CB-11) and lipoplex containing lipofectamine (LipA) and plasmid DNA. To identify the response to treatment, the viability was established using Trypan blue assays. Magnetic resonance imaging (MRI) at 9.4Tesla (T) was applied for localization of the cells in the HFB device. The structural changes in the cells associated with treatment were examined with matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). The tryptic peptides and glycopeptides detected in treated cells provided evidence of the efficacy of antibody binding to the receptor. The results of the study confirmed that cells growth significantly decreased after treatment with antibodies and transfection with lipoplex.
Le texte complet de cet article est disponible en PDF.Keywords : Magnetic resonance imaging, Matrix-assisted laser desorption, CEM cells
Plan
Vol 64 - N° 6
P. 390-395 - juillet 2010 Retour au numéro
Article précédent
- Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-β-carboline)-3-carboxamides
- Lilian T. Düsman Tonin, Manuela Ribeiro Panice, Celso Vataru Nakamura, Karin Juliane Pelizzaro Rocha, Adriana Oliveira dos Santos, Tânia Ueda-Nakamura, Willian Ferreira da Costa, Maria Helena Sarragiotto
- Developmental delay associated with normal thyroidal function and long-term amiodarone therapy during fetal and neonatal life
- Zeljko Mikovic, Natasa Karadzov, Ida Jovanovic, Vedrana Milic, Branislav Tomovic, Amira Egic, Gordana Dragovic Lukic
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?